Nutraplus India Q1 FY22 Profit ₹0.59 Cr; Revenue Surges 1477% Amid Asset Loss

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Nutraplus India Q1 FY22 Profit ₹0.59 Cr; Revenue Surges 1477% Amid Asset Loss
Overview

Nutraplus India reported a Q1 FY22 profit of ₹0.59 Cr on a revenue surge to ₹0.61 Cr (up 1477% YoY). However, the company has lost all plant and equipment, is an NPA, and faces auditor data limitations, raising critical concerns about operational viability despite reported profits.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Nutraplus India Ltd.: ₹0.59 Cr Profit on 1477% Revenue Growth Masks Deep Financial Distress

Nutraplus India reported a standalone net profit of ₹0.59 crore (58.57 Lakhs) for the quarter ended June 30, 2021.
Revenue surged dramatically by 1477% year-on-year to ₹0.61 crore (61.17 Lakhs) from ₹0.04 crore last year.
Reader Takeaway: Profit rebound on revenue surge; severe asset loss and NPA status present significant operational hurdles.

What just happened (today’s filing)

Nutraplus India Ltd. announced its financial results for the quarter ended June 30, 2021. The company reported a standalone net profit of ₹0.59 crore (58.57 Lakhs).

This marks a significant turnaround from the same quarter last year, when the company incurred a net loss. Total income from operations also saw a massive jump.

Standalone revenue for the quarter stood at ₹0.61 crore (61.17 Lakhs), a staggering 1477% increase from ₹0.04 crore in the corresponding quarter of the previous fiscal year.

Total expenses for the quarter were contained at a mere ₹0.03 crore (2.60 Lakhs), contributing to the reported profit.

Why this matters

Despite the headline numbers showing a profitable quarter and exceptional revenue growth, the underlying financial and operational health of Nutraplus India remains critically impaired.

The company explicitly stated the loss of all its property, plants, and equipment under the SARFEASI Act, 2002. This means the core operational assets are gone.

Furthermore, the company continues to be a Non-Performing Asset (NPA), a status declared in FY 2019-20, indicating severe debt defaults.

The auditors' qualification raises further questions, highlighting the company's failure to provide necessary financial data, which impedes a thorough review.

The backstory (grounded)

Nutraplus India's operational landscape has been severely hampered by significant financial distress. The company has lost crucial manufacturing assets, including land, building, and plant & machinery, through auctions conducted under the Securitisation and Reconstruction of Financial Assets and Enforcement of Security Interest (SARFEASI) Act, 2002, due to mounting loan defaults with banks. [cite: SARFEASI Act Asset Auction Search]

These financial defaults led to major banks declaring Nutraplus India's accounts as Non-Performing Assets (NPA) around FY 2019-20. [cite: NPA Declaration Search]

Compounding these issues, auditors have consistently qualified their reports, citing a significant limitation in scope. This qualification stems from the company's inability to furnish timely and adequate financial data and supporting documents, which is essential for a comprehensive audit. [cite: Auditor Qualification Search]

Adding to the regulatory overhang, Nutraplus India has faced issues with non-compliance regarding the timelines set by SEBI and the Companies Act for the submission of its financial results, attracting scrutiny from regulatory bodies and stock exchanges. [cite: Regulatory Non-Compliance Search]

What changes now

  • The reported profit for Q1 FY22 is overshadowed by severe operational limitations and financial distress.
  • Shareholders must grapple with the reality of the company having lost all its core production assets.
  • The continued NPA status signals ongoing severe debt issues and limited access to further financing.
  • The auditor's qualification erodes confidence in the reliability of the company's reported financial information.
  • Persistent non-compliance raises the risk of further regulatory actions or penalties.

Risks to watch

  • Total loss of property, plant, and equipment under the SARFEASI Act, 2002.
  • Company remains declared a Non-Performing Asset (NPA) since FY 2019-20.
  • Auditor qualification due to the company's failure to provide timely financial data.
  • Ongoing non-compliance with SEBI and Companies Act timelines for financial submissions.

Context metrics (time-bound)

What to track next

  • Any further regulatory actions or penalties from SEBI or stock exchanges.
  • Management's strategy, if any, to address operational continuity post-asset loss.
  • Updates on the company's NPA status and potential debt resolution plans.
  • Future compliance with financial result submission deadlines.
  • Any indications of restructuring, liquidation, or change in control proceedings.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.